ARCHIVES

Other DCT Concepts Approved By Board

This article is from The Cancer Letter archive.

Vol. 14 No. 09 | February 26, 1988

Download PDF Visit The Full Archive

Related Articles

Drug Development: FDA Grants Breakthrough Therapy Designation To CTL019 in ALL

June 11, 2014

Misconduct Finding Is ‘Rare,’ OSI official Tells NCAB

June 14, 1991

Panel Resumes Deliberations

January 4, 1980

ODAC Endorses Tamoxifen Trial, With Modification to Ensure Enrollment of Women At Higher Risk

August 2, 1991

Other Concepts Approves By DCE Board Last Week

June 20, 1986

ACS Awards Professorships To Brugge, Hanahan, Samson; Renews Verma, Wigler.

February 9, 2001